212 related articles for article (PubMed ID: 19031329)
1. Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.
Kamat A; Ravi V; Desai A; Satishchandra P; Satish KS; Kumar M
J Neurovirol; 2009 Jan; 15(1):25-35. PubMed ID: 19031329
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
Gisslén M; Fuchs D; Svennerholm B; Hagberg L
J Acquir Immune Defic Syndr; 1999 Aug; 21(4):271-6. PubMed ID: 10428104
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study.
Gisslén M; Hagberg L; Fuchs D; Norkrans G; Svennerholm B
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):291-5. PubMed ID: 9525428
[TBL] [Abstract][Full Text] [Related]
7. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
8. Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.
Abdulle S; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
AIDS; 2002 Nov; 16(16):2145-9. PubMed ID: 12409735
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM; Price RW
J Infect Dis; 2011 Sep; 204(5):753-60. PubMed ID: 21844301
[TBL] [Abstract][Full Text] [Related]
12. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.
Conrad AJ; Schmid P; Syndulko K; Singer EJ; Nagra RM; Russell JJ; Tourtellotte WW
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):425-35. PubMed ID: 7583438
[TBL] [Abstract][Full Text] [Related]
13. Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.
Bogner JR; Junge-Hülsing B; Kronawitter U; Sadri I; Matuschke A; Goebel FD
Clin Investig; 1992 Aug; 70(8):665-9. PubMed ID: 1392442
[TBL] [Abstract][Full Text] [Related]
14. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
15. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
16. Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?
Nyamweya S; Townend J; Zaman A; Steele SJ; Jeffries D; Rowland-Jones S; Whittle H; Flanagan KL; Jaye A
PLoS One; 2012; 7(9):e44411. PubMed ID: 22970212
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.
Wang SX; Ho EL; Grill M; Lee E; Peterson J; Robertson K; Fuchs D; Sinclair E; Price RW; Spudich S
J Acquir Immune Defic Syndr; 2014 Jul; 66(3):303-10. PubMed ID: 24732871
[TBL] [Abstract][Full Text] [Related]
18. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis.
Morris L; Silber E; Sonnenberg P; Eintracht S; Nyoka S; Lyons SF; Saffer D; Koornhof H; Martin DJ
J Infect Dis; 1998 Feb; 177(2):473-6. PubMed ID: 9466541
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
